Farzan Nima has filed 4 insider transactions across 1 company since June 2023.
Most recent transaction: a grant/award of 5250 shares of Keros Therapeutics, Inc. ($KROS) on June 04, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | Farzan Nima | Not found | A | Common Stock | 5250 | $0.00 | 5,250.0000 | 37,437,652 | 9999.99% | 0.01% |
| June 4, 2025 | Keros Therapeutics, Inc. | $KROS | Farzan Nima | Not found | A | Stock Option (right to buy) | 10500 | $0.00 | 10,500.0000 | 37,437,652 | 9999.99% | 0.03% |
| May 30, 2024 | Keros Therapeutics, Inc. | $KROS | Farzan Nima | Not found | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 29,447,119 | 9999.99% | 0.03% |
| June 6, 2023 | Keros Therapeutics, Inc. | $KROS | Farzan Nima | Director | A | Stock Option (right to buy) | 10000 | $0.00 | 10,000.0000 | 25,241,030 | 9999.99% | 0.04% |